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Goal of Study 
 
• The goal of the study was to test the hypothesis: 
• Since non-nicotine constituents can enhance nicotine’s 
addictive effects in other models6, E-cigarette solution 
will have greater reinforcement enhancement at low to 
moderate doses of nicotine and reduced aversive 
effects at high doses of nicotine when compared to the 
same dose of nicotine alone, therefore having an 
increased abuse liability 
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Background 
 
• Electronic cigarettes (E-cigarettes) are increasing in 
popularity in the United States1 and may be an effective 
and safe method to help people quit smoking conventional 
cigarettes2,3 
• However, E-cigarettes may be harmful to one’s physical 
health4 
• E-cigarettes contain nicotine, the main addictive 
component of tobacco5, meaning E-cigarettes have abuse 
liability 
• Nicotine is considered to be addictive because of its 
primary reinforcing effects and its ability to enhance the 
reinforcing effects of other stimuli (reinforcement 
enhancement)6 
• However, too much nicotine leads to aversive effects, 
limiting the amount of drug intake6 
• The abuse liability of conventional cigarettes is not only 
due to the presence of nicotine, but also to the presence 
of other constituents, like minor alkaloids6 
• The solution used in E-cigarettes also contains other 
constituents, including minor alkaloids7,8, which may 
influence this product’s abuse liability as well 
• Not much research has been done on the components of 
E-cigarettes, but it is essential to understand their effects 
so that the use of E-cigarettes can be better regulated 
Results 
  
• The experiment is not yet complete since data from more rats is 
needed to find significant differences 
• The preliminary data, shown in Figure 1, indicates that there is no 
difference between nicotine alone and the E-cigarette solution at 
low to moderate doses of nicotine 
• The decrease in the ICSS threshold at low to moderate doses 
means that a lower intensity of stimulation will maintain the rat’s 
behavior, reflecting the reinforcement enhancement effects of 
nicotine 
• The E-cigarette solution appears to show a lower ICSS threshold 
than nicotine alone at a dose of 1.0 mg/kg (high dose) 
• At higher doses of nicotine, the increased ICSS threshold means 
that it takes higher levels of stimulation for the rat to maintain its 
previous behavior, reflecting the aversive effects of nicotine 
 
Conclusions 
 
• Again, since there were not enough rats in the experiment, 
significant conclusions cannot yet be made 
• The preliminary data indicates that the non-nicotine components 
of the E-cigarette solution do not play a role in the reinforcement 
enhancement properties of the product since the difference from 
baseline is similar to that of nicotine alone 
• This may indicate that the non-nicotine constituents of E-
cigarettes do not influence the product’s abuse liability 
• However, the E-cigarette solution’s lower ICSS threshold at a 
dose of 1.0 mg/kg may indicate that other constituents in the 
solution have a role in limiting the aversive effects, which may 
mean that more of the drug could be taken before the aversive 
effects occur, increasing its abuse liability 
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Figure 1. Mean ICSS thresholds compared to baseline of rats given injections 
of nicotine alone or Dark Honey E-cigarette solution at doses of varying 
nicotine concentrations. The ICSS thresholds were found of 12 rats given either 
nicotine alone or E-cigarette solution at varying doses of nicotine. Each dot 
represents the mean ICSS threshold as a percentage of the baseline at each dose, 
and the error bars represent the standard error of the mean.  
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Methods 
 
• A rat model was used because it provides an accurate 
representation of the human reaction to nicotine, it allows for 
control of variables, and the use of human subjects is 
avoided9 
• The reinforcement enhancement and aversive effects of 
nicotine were modeled using intracranial self-stimulation 
(ICSS) 
• Using the ICSS model, rats are allowed to respond for 
rewarding electrical brain stimulation10, and in trials where 
the stimulation gradually decreases in intensity, there 
becomes a point where the stimulation is no longer 
rewarding enough to maintain the rat’s response, called the 
ICSS threshold 
• The rats used in the experiment were male Holtzman 
Sprague-Dawley rats housed in a reversed 12 hour 
light/dark cycle with ICSS electrodes implanted in the lateral 
hypothalamus using well-established procedures6 
• The rats were trained on the ICSS procedure according to 
Vlachou10 
• Once the rats had stable ICSS thresholds, twice per week 
they were injected with solutions of nicotine in a saline 
solution or Dark Honey E-cigarette solution containing 
nicotine concentrations of 0, 0.06, 0.125, 0.25, 0.50, 0.75, 
1.0, or 1.25 mg/kg in a counterbalanced order 
• The ICSS thresholds of the rats were tested 10 minutes 
after the injection, which allowed time for the drug to 
distribute to the brain 
• Rats were tested for their ICSS thresholds on the days that 
they were not given drug injections to ensure that their 
thresholds returned to baseline between injections 
